Thus, understanding the interaction among NO, glucose, and insulin as well as defining the role of the NOS/ADMA/DDAH pathway in this process is essential towards complete characterization and development of effective preventative strategies and novel therapeutic agents for diabetes and its cardiovascular complications, including insulin resistance. This evidence concerns the gene DDAH2 and diabetes mellitus.